Avo Artinyan is an Oncology physician. OpenAlex indexes 100 publications with 3,866 citations (h-index 31).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1500 E Duarte Rd
Duarte, CA 91010
Telephone
626-359-8111Registry record last updated 8 Jul 2007.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20252 payments
- Medtronic, Inc.Program year20251 payment
- Vioptix IncProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
33.8%Opioid Agonist33.8%Hydrocodone-Acetaminophen100%Part D≥41 patientsAnti-infectives
26.6%Nitroimidazole Antimicrobial18.7%Metronidazole100%Part D≥21 patientsPenicillins with extended spectrum7.9%Amoxicillin-Clavulanate Potass100%Part D<11 patientsCardiovascular
15.8%Statin7.9%Atorvastatin Calcium100%Part D<11 patientsBeta blocker7.9%Metoprolol Succinate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The impact of tumor location on long-term survival outcomes in patients with right-sided colon cancer
Techniques in Coloproctology
2022 - Adenosquamous carcinoma: An aggressive histologic sub-type of colon cancer with poor prognosis
The American Journal of Surgery
2020 - Role of right hemicolectomy in patients with low-grade appendiceal mucinous adenocarcinoma
The American Journal of Surgery
2019 - Prognostic value of neoadjuvant treatment response in locally advanced rectal cancer
Journal of Surgical Research
2018 - Solitary colon metastasis from renal cell carcinoma nine years after nephrectomy: A case report
International Journal of Surgery Case Reports
2016
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Carl June, MD
University of Pennsylvania
Christopher Benz, MD
Buck Institute for Research on Aging
Christina Fitzmaurice, MD
Gundersen Health System
Beth Karlan, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”